Evidence map›Paper›PMID 34125372›Full record

ArticleInternational journal of clinical pharmacy2021

A theoretically informed, mixed-methods study of pharmacists' aspirations and readiness to implement pharmacist prescribing.

Derek Stewart, Abdulrouf Pallivalapila, Binny Thomas, Yolande Hanssens, Wessam El Kassem, Zachariah Nazar, Moza Al Hail

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Derek StewartCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.ORCID http://orcid.org/0000-0001-7360-8592
Abdulrouf PallivalapilaWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID http://orcid.org/0000-0003-4937-8891
Binny ThomasWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID http://orcid.org/0000-0003-1065-8343
Yolande HanssensWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID http://orcid.org/0000-0002-3859-8648
Wessam El KassemWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID http://orcid.org/0000-0003-2145-7555
Zachariah NazarCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar. znazar@qu.edu.qa.ORCID http://orcid.org/0000-0003-4104-4221
Moza Al HailWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID http://orcid.org/0000-0002-7442-3773

Funding

Hamad Medical Corporation (QA) MRC-01-18-050
6 · The paper itself

Abstract

Background Studies have highlighted advancing clinical pharmacy practice in Qatar. Objective To explore pharmacists' aspirations and readiness to implement pharmacist prescribing. Setting Hamad Medical Corporation (HMC), the main provider of secondary and tertiary care. Method A sequential explanatory mixed-methods design. Questionnaire items were derived from the Consolidated Framework of Implementation Research (CFIR), in domains of: awareness/support; readiness; implementation; and facilitators and barriers. Following piloting, all pharmacists (n = 554) were invited to participate. Questionnaire data were analysed using descriptive and inferential statistics with principal component analysis of attitudinal items. Focus groups were recorded, transcribed and analysed using the Framework Approach. Main outcome measure Aspirations and readiness to implement pharmacist prescribing. Results The response rate was 62.8% (n = 348), with respondents highly supportive of implementation in Qatar (median 4, scale 0-5, extremely supportive). The majority (64.9%, n = 226) considered themselves ready, particularly those more senior (p < 0.05) and classifying themselves innovative (p < 0.01). Outpatient (72.9%, n = 221 agreeing) and inpatient (71.1%, n = 218 agreeing) HMC settings were those perceived as being most ready. PCA identified 2 components, with 'personal attributes' being more positive than 'prescribing support'. Facilitators were access to records, organizational/management support and the practice environment, with physician resistance and scope of practice as barriers. Focus groups provided explanation, with themes in CFIR domains of innovation characteristics, characteristics of individuals and the inner setting. Conclusion HMC pharmacists largely aspire, and consider themselves ready, to be prescribers with inpatient and outpatient settings most ready. CFIR domains and constructs identified as facilitators and barriers should be focus for implementation.

Indexed as

PharmacistsPharmacy Service, HospitalAttitude of Health PersonnelFocus GroupsHumansProfessional RoleSurveys and QuestionnairesClinical pharmacyFrameworkImplementationMixed methodsPharmacistPrescribing

Identifiers

PMID34125372
PMCPMC8642360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.